Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy
Authors
Keywords
-
Journal
RENAL FAILURE
Volume 40, Issue 1, Pages 364-370
Publisher
Informa UK Limited
Online
2018-04-30
DOI
10.1080/0886022x.2018.1450762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence-based clinical practice guidelines for IgA nephropathy 2014
- (2016) Yukio Yuzawa et al. Clinical and Experimental Nephrology
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
- (2016) Kerstin Ebefors et al. BMC Nephrology
- IgA nephropathy
- (2016) Kar Neng Lai et al. Nature Reviews Disease Primers
- IL-22 capacitates dermal fibroblast responses to TNF in scleroderma
- (2015) Nicolò Costantino Brembilla et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration ofRehmannia glutinosaextract
- (2015) Min Zhao et al. BIOMEDICAL CHROMATOGRAPHY
- Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis
- (2015) Qi Zheng et al. BMC Complementary and Alternative Medicine
- Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2
- (2015) Myoung-schook Yoou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model
- (2015) Ying Wei et al. JOURNAL OF ETHNOPHARMACOLOGY
- Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family
- (2015) Erna Sziksz et al. MEDIATORS OF INFLAMMATION
- Glycogen Synthase Kinase-3β Stabilizes the Interleukin (IL)-22 Receptor from Proteasomal Degradation in Murine Lung Epithelia
- (2014) Nathaniel M. Weathington et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hemolytic Streptococcus May Exacerbate Kidney Damage in IgA Nephropathy through CCL20 Response to the Effect of Th17 Cells
- (2014) Ting Meng et al. PLoS One
- Enzyme assisted extraction of polysaccharides from the fruit of Cornus officinalis
- (2013) Qinghong You et al. CARBOHYDRATE POLYMERS
- Acteoside inhibits type Ι allergy through the down-regulation of Ca/NFAT and JNK MAPK signaling pathways in basophilic cells
- (2013) Hideko Motojima et al. Journal of Natural Medicines
- Correlation between polyphenol content and anti-inflammatory activity ofVerbascum phlomoides(mullein)
- (2013) Alice Grigore et al. PHARMACEUTICAL BIOLOGY
- Treatment of Primary Chronic Glomerulonephritis with Rehmannia Glutinosa Acteosides in Combination with the Angiotensin Receptor Blocker Irbesartan: A Randomized Controlled Trial
- (2013) HongYu Qiu et al. PHYTOTHERAPY RESEARCH
- Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy
- (2013) Li Zhu et al. PLoS One
- Chapter 10: Immunoglobulin A nephropathy
- (2012) Kidney International Supplements
- Suppression of microRNA-29 Expression by TGF- 1 Promotes Collagen Expression and Renal Fibrosis
- (2011) B. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice
- (2010) Yayoi Saegusa et al. Clinical and Experimental Nephrology
- TJN-259 Improves Mesangial Lesions in Experimental Immunoglobulin A Nephropathy in ddY Mice
- (2009) Chiharu Sadakane et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started